| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 63527-52-6 | 頭孢噻肟酸; 3-乙酰氧基甲基-7-[2-(2-氨基-4-噻唑基)-2-甲氧亞胺基]-乙酰胺基-3-頭孢-4-羧酸 | Cefotaxime; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,3-[(acetyloxy)methyl]-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,[6R-[6a,7b(Z)]]-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-,(6R,7R)- (9CI); Cefabol; Cefotaxime; Cefotaxime acid; Ceftax; Cephotaxime; Claforan; Omnatax; Taxim; Zeefotax |  | C16H17N5O7S2 | 詳情 | 供應商 |
| 6450-32-4 | Benzenesulfonamide,4-methyl-N-[(4-methylphenyl)sulfonyl]-N-(2-methyl-2H-tetrazol-5-yl)-; Di-p-toluenesulfonamide,N-(2-methyl-2H-tetrazol-5-yl)- (7CI,8CI) |  | C16H17N5O4S2 | 詳情 | 供應商 | |
| 79953-06-3 | Benzenesulfonic acid,4-(2-amino-6,9-dihydro-6-oxo-9-b-D-ribofuranosyl-1H-purin-8-yl)- |  | C16H17N5O8S | 詳情 | 供應商 | |
| 102410-32-2 | Glycine, N,N-dimethyl-,[(6-phenylimidazo[2,1-b]thiazol-5-yl)methylene]hydrazide (9CI); Imidazo[2,1-b]thiazole,glycine deriv. |  | C16H17N5OS | 詳情 | 供應商 | |
| 159210-74-9 | Pyrido[2,3-d]pyrimidine-2,4-diamine,6-[[(4-methoxyphenyl)thio]methyl]-5-methyl- |  | C16H17N5OS | 詳情 | 供應商 | |
| 60397-89-9 | 5'-Adenylic acid,mono[4-(fluorosulfonyl)phenyl] ester (9CI); adenosine-5'-(4-fluorosulfonylphenylphosphate) |  | C16H17FN5O9PS | 詳情 | 供應商 | |
| 93018-64-5 | 9H-Purin-2-amine,9-butyl-6-[[(2,4-dichlorophenyl)methyl]thio]-; 9H-Purine,2-amino-9-butyl-6-[(2,4-dichlorobenzyl)thio]- (7CI); NSC 48718 |  | C16H17Cl2N5S | 詳情 | 供應商 | |
| 71048-88-9 |  | C16H17N5O8S2 | 詳情 | 供應商 |